APAC Cuffless Blood Pressure Monitors Market Industry Trends and Forecast to 2034: Segmented by (Product, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
APAC · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$83.7 MnPlaceholder estimate
Estimate 2025$101.5 Mn23.5% of the global market
Projected 2034$572.8 Mn 464.3%Adds $471.3 Mn over 9 forecast years
CAGR 2025–203421.2%Faster than 94% of 180 Medical Devices markets here
Key players5
APAC is 23.5% of the global market.
Among regions, the largest is North America at $220.4 Mn.
Fastest growing: APAC (this report) at 21.2% a year.
APAC ranks 2nd of 6 by size among regions.
Market size projection
APAC
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$471.3 Mn total, 2026–2034
Year-by-year market size, 2024–2034
Cuffless Blood Pressure Monitors Market market size by year, APAC
Year
Market size
Change that year
Since 2025
2024 (estimate)
$83.7 Mn
—
—
2025 (base)
$101.5 Mn
+$17.8 Mn
—
2026 (forecast)
$123.0 Mn
+$21.5 Mn
+21.2%
2027 (forecast)
$149.1 Mn
+$26.1 Mn
+46.9%
2028 (forecast)
$180.7 Mn
+$31.6 Mn
+78%
2029 (forecast)
$219.0 Mn
+$38.3 Mn
+115.8%
2030 (forecast)
$265.5 Mn
+$46.4 Mn
+161.5%
2031 (forecast)
$321.7 Mn
+$56.3 Mn
+217%
2032 (forecast)
$389.9 Mn
+$68.2 Mn
+284.2%
2033 (forecast)
$472.6 Mn
+$82.7 Mn
+365.6%
2034 (forecast)
$572.8 Mn
+$100.2 Mn
+464.3%
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Aktiia, Omron Healthcare, Samsung Health, Biobeat, Withings (see all)
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The APAC Cuffless Blood Pressure Monitors Market Analysis Executive Summary
Cuffless blood pressure monitors estimate blood pressure from a watch, ring or patch without an inflatable cuff.
Key segments of the cuffless Blood Pressure Monitors market include product (Wrist Wearables, Patches and Smartphone-Based) and use (Consumer and Clinical).
Asia Pacific Cuffless Blood Pressure Monitors market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the cuffless Blood Pressure Monitors market. Doctors are starting to use wearable data in care decisions.
Opportunity
Medical-grade wearables, links to virtual care programs and insurer-funded prevention give the cuffless Blood Pressure Monitors market strong growth.
Market Restraints
Questions about accuracy, data privacy, limited reimbursement and users who stop wearing devices hold back the cuffless Blood Pressure Monitors market.
Competitive Landscape for Cuffless Blood Pressure Monitors Market in APAC
The cuffless Blood Pressure Monitors market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Cuffless Blood Pressure Monitors Market in APAC
Cuffless Blood Pressure Monitors in APAC: rules and payment
In some of the countries we cover here, medical devices are regulated by TGA (Australia)[1], NMPA (China)[2], MDACS (Hong Kong)[3], CDSCO (India)[4], PMDA (Japan)[5], MDA (Malaysia)[6], Medsafe (WAND) (New Zealand)[7], FDA Philippines (Philippines)[8], HSA (Singapore)[9], Thai FDA (Thailand)[10], Ministry of Health (Indonesia)[11], DRAP (Pakistan)[12], MFDS (South Korea)[13] and Ministry of Health (Vietnam)[14]. How care is paid for in some of these countries: Medicare and the PBS (Australia)[15], basic medical insurance (China)[16], the Hospital Authority (Hong Kong)[17], Ayushman Bharat PM-JAY (India)[18], public health insurance (Japan)[19], subsidised public care (Malaysia)[20], Pharmac (New Zealand)[21], PhilHealth (Philippines)[22], MediShield Life (Singapore)[23], the Universal Coverage Scheme (Thailand)[24], JKN (BPJS Kesehatan) (Indonesia)[25], out of pocket and Sehat Sahulat (Pakistan)[26], National Health Insurance (South Korea)[27] and social health insurance (Vietnam)[28].
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how cuffless Blood Pressure Monitors products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Product
4.2 By Use
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Aktiia
7.2 Omron Healthcare
7.3 Samsung
7.4 Biobeat
7.5 Withings
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The cuffless Blood Pressure Monitors market can be segmented based on various criteria, including product, use and end user. Here's a breakdown of the market segmentation
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: FDA 510(k) and PMA databases, 510(k) clearances and PMA approvals since 2015 for devices whose name has this market's words. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Cuffless Blood Pressure Monitors right now, from free public sources.
Patients
High blood pressure (ages 30–79), % of adults 30–79 (WHO)
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
WHO Global Health Observatory.
Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
How big is the Cuffless Blood Pressure Monitors market in Asia Pacific?
Placeholder estimate: about $101.5 Mn in 2025, rising to about $572.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Cuffless Blood Pressure Monitors market in Asia Pacific growing?
Placeholder estimate: about 21.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Cuffless Blood Pressure Monitors market report cover?
The report splits the market by product (Wrist Wearables, Patches, Smartphone-Based), use (Consumer, Clinical) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Cuffless Blood Pressure Monitors market?
Key players include Aktiia, Omron Healthcare, Samsung Health, Biobeat and Withings.
What is driving the Cuffless Blood Pressure Monitors market?
Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the cuffless Blood Pressure Monitors market. Doctors are starting to use wearable data in care decisions.
How much research is published on Cuffless Blood Pressure Monitors?
PubMed lists 220 papers on Cuffless Blood Pressure Monitors added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.